These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6106040)

  • 1. Biochemistry and treatment strategies for depression.
    Garvey MJ
    J Fam Pract; 1980 Aug; 11(2):215-9. PubMed ID: 6106040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tricyclic antidepressants on individual symptoms.
    Welner A; Welner Z; Robins E
    J Clin Psychiatry; 1980 Sep; 41(9):306-9. PubMed ID: 7410324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
    Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who benefits from tricyclic antidepressants: a survey.
    Goldberg SC; Tilley DH; Friedel RO; Hamer RM; Ban TA; Brockett C; Bale P; Stephens V
    J Clin Psychiatry; 1988 Jun; 49(6):224-8. PubMed ID: 3379027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Different urinary excretion of 3-methoxy-4-hydroxyphenyl-glycol and response to tricyclic antidepressive drugs].
    Beckmann H; Jones C; Goodwin FK
    Arzneimittelforschung; 1974 Jul; 24(7):1010-2. PubMed ID: 4408047
    [No Abstract]   [Full Text] [Related]  

  • 7. Prediction of tricyclic antidepressant response: a critical review.
    Bielski RJ; Friedel RO
    Arch Gen Psychiatry; 1976 Dec; 33(12):1479-89. PubMed ID: 793564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
    Maas JW; Koslow SH; Katz MM; Bowden CL; Gibbons RL; Stokes PE; Robins E; Davis JM
    Am J Psychiatry; 1984 Oct; 141(10):1159-71. PubMed ID: 6207736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent concepts of neuromodulators in affective disorders.
    Beckmann H
    Encephale; 1982; 8(2):164-76. PubMed ID: 6125377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
    Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
    Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricyclic antidepressants (first of two parts).
    Hollister LE
    N Engl J Med; 1978 Nov; 299(20):1106-9. PubMed ID: 30045
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluoxetine and imipramine: are there differences in cost-utility for depression in primary care?
    Serrano-Blanco A; Suárez D; Pinto-Meza A; Peñarrubia MT; Haro JM;
    J Eval Clin Pract; 2009 Feb; 15(1):195-203. PubMed ID: 19239602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in depression associated with neurologic illness: clinical correlates and pharmacologic response.
    Okiishi CG; Paradiso S; Robinson RG
    J Gend Specif Med; 2001; 4(2):65-72. PubMed ID: 11480103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemistry of depression. Literature analysis].
    Moussaoui D
    Encephale; 1978; 4(3):193-222. PubMed ID: 30616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood levels of tricyclics and evolution of depressive syndrome during therapy].
    Bourgeois ML; Tignol J
    Ann Med Psychol (Paris); 1978 May; 136(5):744-9. PubMed ID: 742787
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of drug research to investigating the nature of endogenous depression.
    Carlsson A
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):2-10. PubMed ID: 10584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The tolerability and efficacy of combined antidepressant therapy: literature review].
    Taleb M; Gorwood P; Bouleau JH; Rouillon F
    Encephale; 1996; 22(6):450-60. PubMed ID: 10901838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.